Advertisement
Advertisement
U.S. markets open in 1 hour 11 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Denali Therapeutics Inc. (DNLI)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
31.24+1.81 (+6.15%)
At close: 04:00PM EDT
31.30 +0.06 (+0.19%)
Pre-Market: 08:17AM EDT
Advertisement
Advertisement
Show:
Annual
Subscribe to Yahoo Finance Plus Essential to download historical data

Income Statement

All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Breakdown
ttm
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Total Revenue
82,879
48,661
335,659
26,678
129,160
Operating Expense
373,908
344,412
272,941
239,862
175,532
Operating Income
-291,029
-295,751
62,718
-213,184
-46,372
Net Non Operating Interest Income Expense
4,694
4,595
9,241
15,219
10,132
Pretax Income
-286,335
-291,156
71,959
-197,965
-36,240
Tax Provision
-
-575
823
-351
-
Net Income Common Stockholders
-285,760
-290,581
71,136
-197,614
-36,240
Diluted NI Available to Com Stockholders
-285,760
-290,581
71,136
-197,614
-36,240
Basic EPS
-
-2.39
0.65
-2.07
-0.39
Diluted EPS
-
-2.39
0.63
-2.07
-0.39
Basic Average Shares
-
121,525
108,974
95,608
92,622
Diluted Average Shares
-
121,525
112,703
95,608
92,622
Total Operating Income as Reported
-291,029
-295,751
62,718
-213,184
-46,372
Total Expenses
373,908
344,412
272,941
239,862
175,532
Net Income from Continuing & Discontinued Operation
-285,760
-290,581
71,136
-197,614
-36,240
Normalized Income
-285,760
-290,581
71,136
-197,614
-36,240
Interest Income
4,694
4,595
-
15,219
10,132
Net Interest Income
4,694
4,595
9,241
15,219
10,132
EBIT
-291,029
-295,751
62,718
-213,184
-46,372
EBITDA
-282,465
-
-
-
-
Reconciled Depreciation
8,564
8,593
8,531
7,991
7,415
Net Income from Continuing Operation Net Minority Interest
-285,760
-290,581
71,136
-197,614
-36,240
Normalized EBITDA
-282,465
-287,158
71,249
-205,193
-38,957
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
Advertisement
Advertisement